The global laparotomy sponge market size is expected to reach USD 2.06 billion by 2033, registering a CAGR of 5.9% from 2025 to 2033, according to a new report by Grand View Research, Inc. Rising disease burden and subsequent improvement in treatment alternatives, growing geriatric population, and a mounting number of cesarean deliveries are among key trends contributing to the growth of the market. Furthermore, R&D initiatives undertaken by leading players to improve counting and detection of sponges to prevent incidences of retained surgical items (RSI) are driving the market.
The number of abdominal surgeries performed every year is increasing tremendously owing to a rise in the prevalence of abdominal disorders. Cesarean section and cholecystectomy (removal of gall bladder) are among the top ten most commonly performed surgeries in the U.S. Growing prevalence of cancer is leading to an upswing in laparotomy procedures for biopsies, which in turn is anticipated to provide a fillip to the market.
Moreover, the development of technologically advanced sponge counting and detection systems is estimated to help the market gain significant traction over the coming years. For example, in June 2007, ClearCount Medical received FDA clearance for SmartSponge System. It was reportedly the world’s first RFID system for detection and counting of surgical towels and sponges to replace the manual counting method.
Various initiatives are being undertaken to reduce the incidence of RSI. A pediatric teaching hospital in Boston, Children’s Hospital Boston, conducted a quality improvement study for eliminating incorrect counts and count discrepancies. This study was focused on educating perioperative staff, reviewing prior count discrepancies, standardizing counting practice, and reviewing and revising the counting system for reducing RSI. This initiative resulted in a reduction in RSI by 50% between 2009 and 2010.
Request a free sample copy or view report summary: Laparotomy Sponge Market Report
The radiopaque laparotomy sponge segment accounted for the largest revenue share in 2024, due to increasing emphasis on surgical safety and post-operative accountability.
The hospital & clinics segment accounted for the largest revenue share in 2024. This growth is driven by the high volume of surgical procedures conducted in these settings.
The North America laparotomy sponge market with the largest revenue share of 37.5% in 2024, driven by a rise in surgical procedures, increased awareness around retained surgical items (RSIs), and the increasing adoption of radiofrequency identification (RFID) and barcode-based tracking systems.
Grand View Research has segmented the laparotomy sponge market on the basis of product, end use, and region:
Laparotomy Sponge Product Outlook (Revenue, USD Million, 2021 - 2033)
Radiopaque Laparotomy Sponge
Traditional Laparotomy Sponge
RFID Laparotomy Sponge
Laparotomy Sponge End Use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals & Clinics
Others
Laparotomy Sponge Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Laparotomy Sponge Market
Integra LifeSciences
Medical Action Industries Inc.
SDP Inc.
Dukal, LLC
Stryker
Cardinal Health
AllCare
DeRoyal Industries Inc.
Allmed Medical Products Co.,Ltd.
Premier Enterprises
"The quality of research they have done for us has been excellent..."